Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.116 EUR | -0.42% | -1.21% | +1.20% |
05-15 | Compugen Names David Silberman CFO | MT |
05-09 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
95.07M | - | - | - | |||
63.85B | - | |||||
41.83B | ||||||
40.65B | ||||||
27.12B | ||||||
26.52B |